Cardiovascular risk factors early in the course of treatment in people with type 2 diabetes without established cardiovascular disease: a population‐based observational retrospective cohort study
Source : https://onlinelibrary.wiley.com/doi/10.1111/dme.14697?af=R
This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between...
Conclusions
These analyses provide important information to identify people who may benefit from primary prevention of cardiovascular disease. Modifiable cardiovascular risk factors should be controlled early in all individuals with type 2 diabetes (as well as in all individuals with cardiovascular disease).
Signaling defects associated with insulin resistance in non-diabetic and diabetic individuals and modification by sex
Source : https://www.jci.org/articles/view/151818
Insulin resistance is present in one-quarter of the general population, predisposing to a wide-range of diseases. Our aim was to identify cell-intrinsic determinants of insulin resistance in this population using...
Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study
Source : https://onlinelibrary.wiley.com/doi/full/10.1111/jdi.13647
Davood Khalili , Farzad Hadaegh , Corresponding Author Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran Correspondence Farzad Hadaegh...
Study Uncovers New Link Between Long-term Arsenic Exposure and Type 2 Diabetes
A University of Arizona Health Sciences study has identified the biological mechanism linking long-term arsenic exposure to diseases such as cancer and Type 2 diabetes. The findings could result in...
Signaling Defects
Source : https://hms.harvard.edu/news/signaling-defects
In what could be a starting point for new therapeutics to tackle insulin resistance, a major driver of type 2 diabetes and metabolic syndrome present in 20-30 percent of the...